SG Americas Securities
STOK icon

SG Americas Securities’s Stoke Therapeutics STOK Stock Holding History

SG Americas Securities’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
5,625
-28,371
-83% -$910K ﹤0.01% 2836
2026
Q1 		$1.11M Buy
33,996
+8,160
+32% +$268K ﹤0.01% 1706
2025
Q4 		$820K Buy
25,836
+16,840
+187% +$506K ﹤0.01% 2168
2025
Q3 		$211K Buy
+8,996
New +$154K ﹤0.01% 2722
2025
Q1 		– Sell
-10,768
Closed -$119K – 3753
2024
Q4 		$119K Sell
10,768
-4,149
-28% -$51K ﹤0.01% 2605
2024
Q3 		$183K Sell
14,917
-53,684
-78% -$760K ﹤0.01% 2576
2024
Q2 		$927K Buy
68,601
+58,943
+610% +$796K 0.01% 1338
2024
Q1 		$130K Sell
9,658
-5,443
-36% -$33K ﹤0.01% 2337
2023
Q4 		$79K Buy
15,101
+1,544
+11% +$6.6K ﹤0.01% 2834
2023
Q3 		$53K Buy
+13,557
New +$89.1K ﹤0.01% 2928
2022
Q4 		– Sell
-7,933
Closed -$102K – 3361
2022
Q3 		$102K Buy
+7,933
New +$126K ﹤0.01% 2852
2022
Q2 		– Sell
-182,591
Closed -$3.84M – 3602
2022
Q1 		$3.84M Buy
182,591
+152,149
+500% +$3.05M 0.03% 547
2021
Q4 		$730K Sell
30,442
-11,372
-27% -$271K ﹤0.01% 1876
2021
Q3 		$1.06M Buy
41,814
+24,697
+144% +$689K 0.01% 1861
2021
Q2 		$576K Buy
17,117
+2,649
+18% +$93.6K ﹤0.01% 1878
2021
Q1 		$562K Buy
+14,468
New +$824K ﹤0.01% 1944
2020
Q4 		– Sell
-25,526
Closed -$855K – 3467
2020
Q3 		$855K Buy
25,526
+246
+1% +$7.02K 0.01% 1278
2020
Q2 		$602K Buy
25,280
+18,497
+273% +$439K 0.01% 1912
2020
Q1 		$155K Buy
6,783
+2,691
+66% +$66.5K ﹤0.01% 2694
2019
Q4 		$116K Buy
+4,092
New +$103K ﹤0.01% 2866
2019
Q3 		– Sell
-13,400
Closed -$391K – 3198
2019
Q2 		$391K Buy
+13,400
New +$360K ﹤0.01% 2035

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities's STOK Position: Q2 2026 in Review

SG Americas Securities reduced its Stoke Therapeutics (STOK) stake by 83% in Q2 2026, selling an estimated $910K and leaving 5,625 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

SG Americas Securities first reported a position in STOK in Q2 2019 and has held it in 21 quarters since. The position peaked at $3.84M in Q1 2022. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • SG Americas Securities held 5,625 shares of Stoke Therapeutics worth $184K as of Q2 2026.
  • SG Americas Securities sold 28,371 Stoke Therapeutics shares in Q2 2026, an estimated $910K.
  • Stoke Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2836 holding.
  • SG Americas Securities first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 21 quarters since.
  • SG Americas Securities's Stoke Therapeutics position peaked at $3.84M in Q1 2022.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.